Hyaluronan induces cell death in activated T cells through CD44

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 7044-7054

  Ruffell, Brian ^a   Johnson, Pauline ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FAS ANTIGEN; HERMES ANTIGEN; HYALURONIC ACID; CD44 PROTEIN, HUMAN; CHONDROITIN SULFATE; FAS LIGAND; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOLECULAR WEIGHT; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; ANIMAL; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MOUSE MUTANT; NICK END LABELING; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD44; ANTIGENS, CD95; BLOTTING, WESTERN; CELL DEATH; CHONDROITIN SULFATES; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; HYALURONIC ACID; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, MUTANT STRAINS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSFECTION;

EID: 58149181980     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.7044     Document Type: Article

References (59)

1. Ponta, H., L. Sherman, and P. A. Herrlich. 2003. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4: 33-45. (Pubitemid 36077255)
2. Johnson, P., A. Maiti, K. L. Brown, and R. Li. 2000. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem. Pharm. 59: 455-465.
3. Pure, E., and C. A. Cuff. 2001. A crucial role for CD44 in inflammation. Trends Mol. Med. 7: 213-221.
4. Lesley, J., R. Hyman, N. English, J. B. Catterall, and G. A. Turner. 1997. CD44 in inflammation and metastasis. Glycoconj. J. 14: 611-622.
5. Stern, R., A. A. Asari, and K. N. Sugahara. 2006. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 85: 699-715.
6. Toole, B. P. 2004. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4: 528-539.
7. Cuff, C. A., D. Kothapalli, I. Azonobi, S. Chun, Y. M. Zhang, R. Belkin, C. Yeh, A. Secreto, R. K. Assoian, D. J. Rader, and E. Pure. 2001. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Invest. 108: 1031-1040.
8. Stoop, R., H. Kotani, J. D. McNeish, I. G. Otterness, and K. Mikecz. 2001. Increased resistance to collagen-induced arthritis in CD44-deficient DBA/1 mice. Arthritis Rheum. 44: 2922-2931. (Pubitemid 34016212)
9. Teder, P., R. W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Pure, P. M. Henson, and P. W. Noble. 2002. Resolution of lung inflammation by CD44. Science 296: 155-158.
10. Hayer, S., G. Steiner, B. Gortz, E. Reiter, M. Tohidast-Akrad, M. Amling, O. Hoffmann, K. Redlich, J. Zwerina, K. Skriner, et al. 2005. CD44 is a determinant of inflammatory bone loss. J. Exp. Med. 201: 903-914. (Pubitemid 40524460)
11. Budd, R. C., J. C. Cerottini, C. Horvath, C. Bron, T. Pedrazzini, R. C. Howe, and H. R. MacDonald. 1987. Distinction of virgin and memory T lymphocytes: stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 138: 3120-3129.
12. Lesley, J., N. Howes, A. Perschl, and R. Hyman. 1994. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 180: 383-387. (Pubitemid 24181089)
13. Lesley, J., R. Hyman, and P. W. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54: 271-335. (Pubitemid 23289255)
14. Galandrini, R., E. Galluzzo, N. Albi, C. E. Grossi, and A. Velardi. 1994. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J. Immunol. 153: 21-31. (Pubitemid 24186515)
15. Mummert, M. E., D. Mummert, D. Edelbaum, F. Hui, H. Matsue, and A. Takashima. 2002. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J. Immunol. 169: 4322-4331.
16. Do, Y., P. S. Nagarkatti, and M. Nagarkatti. 2004. Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells. J. Immunother. 27: 1-12. (Pubitemid 38076164)
17. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195: 99-111. (Pubitemid 34074500)
18. DeGrendele, H. C., P. Estess, L. J. Picker, and M. H. Siegelman. 1996. CD44 and its ligand hyaluronate mediate rolling under physiologic flow - a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 183: 1119-1130.
19. Mohamadzadeh, M., H. Degrendele, H. Arizpe, P. Estess, and M. Siegelman. 1998. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J. Clin. Invest. 101: 97-108. (Pubitemid 28058908)
20. + Th1 and Th2 lymphocytes to roll and adhere. Blood 107: 4798-4806.
21. Nandi, A., P. Estess, and M. Siegelman. 2004. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 20: 455-465. (Pubitemid 38482123)
22. DeGrendele, H. C., P. Estess, and M. H. Siegelman. 1997. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278: 672-675.
23. Krammer, P. H., R. Arnold, and I. N. Lavrik. 2007. Life and death in peripheral T cells. Nat. Rev. Immunol. 7: 532-542.
24. McKallip, R. J., Y. Do, M. T. Fisher, J. L. Robertson, P. S. Nagarkatti, and M. Nagarkatti. 2002. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. Int. Immunol. 14: 1015-1026.
25. Chen, D., R. J. McKallip, A. Zeytun, Y. Do, C. Lombard, J. L. Robertson, T. W. Mak, P. S. Nagarkatti, and M. Nagarkatti. 2001. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. J. Immunol. 166: 5889-5897. (Pubitemid 32440712)
26. Do, Y., A. Q. Rafi-Janajreh, R. J. McKallip, P. S. Nagarkatti, and M. Nagarkatti. 2003. Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease. Int. Immunol. 15: 1327-1340. (Pubitemid 37369326)
27. Weber, G. F. 2004. The absence of CD44 ameliorates Fas(lpr/lpr) disease. Autoimmunity 37: 1-8.
28. Mielgo, A., V. Brondani, L. Landmann, A. Glaser-Ruhm, P. Erb, D. Stupack, and U. Gunthert. 2007. The CD44 standard/ezrin complex regulates Fas-mediated apoptosis in Jurkat cells. Apoptosis 12: 2051-2061. (Pubitemid 47498223)
29. Nakano, K., K. Saito, S. Mine, S. Matsushita, and Y. Tanaka. 2007. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death. Apoptosis 12: 45-54. (Pubitemid 46009503)
30. Ayroldi, E., L. Cannarile, G. Migliorati, A. Bartoli, I. Nicoletti, and C. Riccardi. 1995. CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 86: 2672-2678.
31. Larkin, J., G. J. Renukaradhya, V. Sriram, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz. 2006. CD44 differentially activates mouse NK T cells and conventional T cells. J. Immunol. 177: 268-279. (Pubitemid 43939138)
32. Dougherty, G. J., D. L. Cooper, J. F. Memory, and R. K. Chiu. 1994. Ligand binding specificity of alternatively spliced CD44 isoforms: recognition and binding of hyaluronan by CD44R1. J. Biol. Chem. 269: 9074-9078.
33. de Belder, A. N., and K. O. Wik. 1975. Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr. Res. 44: 251-257.
34. Dougherty, G. J., P. M. Lansdorp, D. L. Cooper, and R. K. Humphries. 1991. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoetic cells. J. Exp. Med. 174: 1-5.
35. Ruffell, B., and P. Johnson. 2005. Chondroitin sulfate addition to CD44H negatively regulates hyaluronan binding. Biochem. Biophys. Res. Commun. 334: 306-312.
36. Ikegami-Kawai, M., and T. Takahashi. 2002. Microanalysis of hyaluronan oligosaccharides by polyacrylamide gel electrophoresis and its application to assay of hyaluronidase activity. Anal. Biochem. 311: 157-165.
37. Schmits, R., J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation and tumorigenicity. Blood 90: 2217-2233.
38. Peach, R. J., D. Hollenbaugh, I. Stamenkovic, and A. Aruffo. 1993. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122: 257-264.
39. Bajorath, J., B. Greenfield, S. B. Munro, A. J. Day, and A. Aruffo. 1998. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J. Biol. Chem. 273: 338-343.
40. Holmstrom, T. H., S. C. Chow, I. Elo, E. T. Coffey, S. Orrenius, L. Sistonen, and J. E. Eriksson. 1998. Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. J. Immunol. 160: 2626-2636.
41. Makatsori, E., N. K. Karamanos, N. Papadogiannakis, A. Hjerpe, E. D. Anastassiou, and T. Tsegenidis. 2001. Synthesis and distribution of glycosaminoglycans in human leukemic B- and T-cells and monocytes studied using specific enzymic treatments and high-performance liquid chromatography. Biomed. Chromatogr. 15: 413-417. (Pubitemid 32895622)
42. Ayroldi, E., L. Cannarile, and C. Riccardi. 1996. Modulation of superantigen-induced t-cell deletion by antibody anti-pgp-1 (cd44). Immunology 87: 191-197.
43. Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158: 4602-4611.
44. Hildeman, D. A., T. Mitchell, T. K. Teague, P. Henson, B. J. Day, J. Kappler, and P. C. Marrack. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10: 735-744.
45. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687.
46. Jaattela, M., and J. Tschopp. 2003. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4: 416-423.
47. Frankfurt, O. S., and A. Krishan. 2001. Identification of apoptotic cells by formamide-induced DNA denaturation in condensed chromatin. J. Histochem. Cytochem. 49: 369-378.
48. Lenardo, M. J. 1991. Interleukin-2 programs mouse α β T lymphocytes for apoptosis. Nature 353: 858-861.
49. Artus, C., E. Maquarre, R. S. Moubarak, C. Delettre, C. Jasmin, S. A. Susin, and J. Robert-Lezenes. 2006. CD44 ligation induces caspase-independent cell death via a novel calpain/AIF pathway in human erythroleukemia cells. Oncogene 25: 5741-5751.
50. Ly, J. D., D. R. Grubb, and A. Lawen. 2003. The mitochondrial membrane potential (δpsi(m)) in apoptosis; an update. Apoptosis 8: 115-128.
51. Deas, O., C. Dumont, M. MacFarlane, M. Rouleau, C. Hebib, F. Harper, F. Hirsch, B. Charpentier, G. M. Cohen, and A. Senik. 1998. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J. Immunol. 161: 3375-3383.
52. Klaus, S. J., S. P. Sidorenko, and E. A. Clark. 1996. CD45 ligation induces programmed cell death in T and B lymphocytes. J. Immunol. 156: 2743-2753.
53. Mateo, V., L. Lagneaux, D. Bron, G. Biron, M. Armant, G. Delespesse, and M. Sarfati. 1999. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat. Med. 5: 1277-1284.
54. Pettersen, R. D., G. Bernard, M. K. Olafsen, M. Pourtein, and S. O. Lie. 2001. CD99 signals caspase-independent T cell death. J. Immunol. 166: 4931-4942.
55. Lesage, S., A. M. Steff, F. Philippoussis, M. Page, S. Trop, V. Mateo, and P. Hugo. 1997. CD4+ CD8+ thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway. J. Immunol. 159: 4762-4771.
56. Lesley, J., I. Gal, D. J. Mahoney, M. R. Cordell, M. S. Rugg, R. Hyman, A. J. Day, and K. Mikecz. 2004. TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J. Biol. Chem. 279: 25745-25754.
57. Zhuo, L., A. Kanamori, R. Kannagi, N. Itano, J. Wu, M. Hamaguchi, N. Ishiguro, and K. Kimata. 2006. SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. J. Biol. Chem. 281: 20303-20314.
58. Schlegel, R. A., M. K. Callahan, and P. Williamson. 2000. The central role of phosphatidylserine in the phagocytosis of apoptotic thymocytes. Ann. NY Acad. Sci. 926: 217-225.
59. Firan, M., S. Dhillon, P. Estess, and M. H. Siegelman. 2006. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood 107: 619-627.